When Venous Thrombosis May Hide an Underlying Cancer
Di Stefania Cavazza | 20 Agosto 2026 | 0
Ultima modifica: 21 Agosto 2026
When a deep vein thrombosis or pulmonary embolism occurs without apparent causes (unprovoked venous thromboembolism, VTE), a question often arises: could there be a hidden tumour? The scientific community has long debated the value of searching for it through extensive diagnostic testing. Two new studies, one of which was presented at the 2026 International Society on Thrombosis and Haemostasis (ISTH) Congress, highlight the importance of an “individualized” diagnostic pathway guided by clinical judgment. But there are many new developments brewing—from risk scores to proteomics to liquid biopsy—to help identify which patients truly warrant further diagnostic investigations.
Unprovoked venous thromboembolism: patient perspectives
Di Nicoletta Riva | 21 Luglio 2026 | 0
Ultima modifica: 3 Agosto 2026
The Dalì study Presented at the International Society on Thrombosis and Haemostasis 2026 Congress...
Aspirin for the Prevention of Venous Thromboembolism After Hip and Knee Arthroplasty?
Di Stefania Cavazza | 20 Luglio 2026 | 0
Ultima modifica: 3 Agosto 2026
Canadian investigators went beyond the EPCAT II trial (1) and presented the EPCAT III study at the Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2026 in Paris. The double-blind randomized trial, simultaneously published in the New England Journal of Medicine, compared antithrombotic prophylaxis with aspirin (ASA) alone versus rivaroxaban followed by ASA after hip or knee arthroplasty (2).
Persistent positivity of Antiphospholipid Antibodies: results from the START2 Registry
Di Stefania Cavazza | 20 Luglio 2026 | 0
Ultima modifica: 3 Agosto 2026
Presented at the ISTH 2026 Congress in Paris and simultaneously published on Thrombosis Research, the results of the START2 observational study describe five hundred patients with persistently positive antiphospholipid antibodies (aPL) followed in major Italian Thrombosis Centers (1).
